Clinical Trials

Showing trials with last updates posted in 2026.

NCT03505320 | ACTIVE_NOT_RECRUITING | PHASE2
143 participants

A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2018-06-29
Completion:
2027-06-30
Conditions
  • Pharmacokinetics of Zolbetuximab
  • Gastric Cancer
  • Gastro-esophageal Junction (GEJ) Cancer
  • Pharmacokinetics of Oxaliplatin
  • Pharmacokinetics of Fluorouracil Bolus (5-FU)
Interventions
  • DRUG
No Results Yet
NCT02954874 | ACTIVE_NOT_RECRUITING | PHASE3
1195 participants

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-31
Start Date:
2017-01-18
Completion:
2026-08-03
Conditions
  • Breast Carcinoma In Situ
  • Invasive Breast Carcinoma
  • Stage I Breast Cancer AJCC v7
  • Stage II Breast Cancer AJCC v6 and v7
  • Stage III Breast Cancer AJCC v7
  • Triple-Negative Breast Carcinoma
Interventions
  • PROCEDURE
  • OTHER
  • BIOLOGICAL
  • RADIATION
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page